How many insider declarations has Sarraf Pasha filed?

Sarraf Pasha has filed 3 public insider declarations with SEC (Form 4).

What is Sarraf Pasha's role?

Sarraf Pasha's reported role is not specified by the regulator across the filings.

Which companies does Sarraf Pasha report trades for?

Sarraf Pasha reports trades for Cue Biopharma, Inc..

What is Sarraf Pasha's declared buy vs sell volume?

Across the available history, declared buys total 1k€ and disposals 0.

← Executives ★ Sign in to follow

SP

Sarraf Pasha

OFFICERM

·SEC (Form 4)

Cue Biopharma, Inc.

0

Total declarations

0

Company

€1,111

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

T+90 hit rate

0%

T+90 mean return

-53.8%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

No signal scores available.

Explore the full record of transactions filed by Sarraf Pasha. Director active across 1 company, notably Cue Biopharma, Inc.. Cumulatively, 3 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €1k. History available since 30 December 2025. The latest transaction was filed on 9 July 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Sarraf Pasha

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Cue Biopharma, Inc. (US)

Declarations3 total

◆

Sarraf Pasha

DirectorExecutives9 Jul 2026Cue Biopharma, Inc.

0SEC ↗

18,400 shares0Common StockSEC:0002059447-26-000006:0

◆

Sarraf Pasha

DirectorExecutives9 Jul 2026Cue Biopharma, Inc.

0SEC ↗

21,800 shares0Common StockSEC:0002059447-26-000004:0

▲

Sarraf Pasha

DirectorExecutives30 Dec 2025Cue Biopharma, Inc.

$1,30823SEC ↗

4,229 shares@ US$0.3094100.0% of flowCommon StockSEC:0001193125-26-000900:0

Canonical exit: 30 Mar 2026 (T+90)

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

SP

Sarraf Pasha

OFFICERM

·SEC (Form 4)

Cue Biopharma, Inc.

0

Total declarations

0

Company

€1,111

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

0

T+90 hit rate

0%

T+90 mean return

-53.8%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

No signal scores available.

Explore the full record of transactions filed by Sarraf Pasha. Director active across 1 company, notably Cue Biopharma, Inc.. Cumulatively, 3 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €1k. History available since 30 December 2025. The latest transaction was filed on 9 July 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.